JPMorgan Funds - Thematics - Genetic Therapies Fund C2 (acc) SGD (hedged)
ISIN LU2053354986 / Valor 50098940
JPMorgan Funds - Thematics - Genetic Therapies Fund C2 (acc) SGD (hedged)
UMushroom community rating:
JPM Thematics Genetic Therapies invests worldwide in companies that are deeply involved in developing and advancing genetic therapies. The fund utilizes advanced technology to analyze and identify firms with significant contributions to the genetic therapies field. Additionally, a team of specialized analysts reviews these selections to ensure each company not only has strong relevance and revenue from genetic therapies but also maintains high quality, good liquidity, and substantial market presence. This approach ensures the portfolio is focused on leading players in the genetic medicine sector.
Ratings & reviews
OTHER SHARE CLASSES OF THIS FUND
